543 related articles for article (PubMed ID: 18448968)
1. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
Isaacs D
Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
[TBL] [Abstract][Full Text] [Related]
3. Oral nystatin prophylaxis and neonatal fungal infections.
Howell A; Isaacs D; Halliday R;
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants.
Aydemir C; Oguz SS; Dizdar EA; Akar M; Sarikabadayi YU; Saygan S; Erdeve O; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F164-8. PubMed ID: 20659937
[TBL] [Abstract][Full Text] [Related]
6. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis for the prevention of neonatal candidiasis?
O'Grady MJ; Dempsey EM
Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
Aziz M; Patel AL; Losavio J; Iyengar A; Berven M; Schloemer N; Jakubowicz A; Mathai T; McAuley JB
Pediatr Infect Dis J; 2010 Apr; 29(4):352-6. PubMed ID: 19934791
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Donowitz LG
N Engl J Med; 2001 Dec; 345(23):1660-6. PubMed ID: 11759644
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants.
Violaris K; Carbone T; Bateman D; Olawepo O; Doraiswamy B; LaCorte M
Am J Perinatol; 2010 Jan; 27(1):73-8. PubMed ID: 19504425
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
Bertini G; Perugi S; Dani C; Filippi L; Pratesi S; Rubaltelli FF
J Pediatr; 2005 Aug; 147(2):162-5. PubMed ID: 16126042
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole prophylaxis against fungal infection in preterm infants.
Casalaz D
N Engl J Med; 2002 Jun; 346(24):1913-4; author reply 1913-4. PubMed ID: 12066811
[No Abstract] [Full Text] [Related]
13. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Clerihew L; Austin N; McGuire W
Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia.
Ganesan K; Harigopal S; Neal T; Yoxall CW
Arch Dis Child Fetal Neonatal Ed; 2009 Jul; 94(4):F275-8. PubMed ID: 19036756
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
[TBL] [Abstract][Full Text] [Related]
16. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.
Parikh TB; Nanavati RN; Patankar CV; Rao S; Bisure K; Udani RH; Mehta P
Indian Pediatr; 2007 Nov; 44(11):830-7. PubMed ID: 18057479
[TBL] [Abstract][Full Text] [Related]
18. "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.
Kaufman DA
Early Hum Dev; 2012 May; 88 Suppl 2():S45-9. PubMed ID: 22633513
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Austin NC; Darlow B
Cochrane Database Syst Rev; 2004; (1):CD003478. PubMed ID: 14974017
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole prophylaxis in high-risk neonates.
Reed BN; Caudle KE; Rogers PD
Ann Pharmacother; 2010 Jan; 44(1):178-84. PubMed ID: 20040701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
